Europe and Middle East & Africa Cardiac Microcatheters Market Growth and Recent Trends by 2028

The Europe and Middle East & Africa cardiac microcatheter market was valued at US$ 95.76 million in 2022 and is expected to reach US$ 136.05 million by 2028; it is estimated to register a CAGR of 6.1% from 2023 to 2028.

The Europe and Middle East & Africa cardiac microcatheter market is bifurcated on the basis of indication and end user. Based on indication, the market is bifurcated into general peripheral vascular and coronary. Based on end user, the market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. This report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends and market dynamics, along with the competitive analysis of the leading market players in Europe and Middle East & Africa.

Market Insights

Upsurge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheters

As a coronary interventional tool, microcatheters support the performance of invasive endovascular procedures by fulfilling a wide range of functions in these complex vascular anatomies. Manufacturers are investing in research and development of technologies, which has led to the development of new and advanced products, along with an upsurge in product approvals in Europe and Middle East & Africa.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Europe and Middle East & Africa Cardiac Microcatheters Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

A few product approvals and developments are listed below:

• In 2019, Navitian, a new coronary microcatheter from iVascular, received the CE mark approval. The device was approved to facilitate, guide, and support a guidewire while accessing the coronary system, exchanging guidewires, and injecting radiopaque contrast media or saline solutions.
• In 2021, Baylis Medical announced the launch of the first clinical case of the JLL 2-French electrophysiology microcatheter in Europe. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, thereby introducing the smallest diagnostic catheter available in the European market. The 2F microcatheter also allows mapping and pacing in smaller anatomy such as the Vein of Marshall (VOM).
• In 2020, Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System. FFR measurements provide an assessment of arterial lesion severity and inform intervention strategy in both diagnosis and treatment of coronary artery disease.

Moreover, in 2023, Al Qassimi Hospital in the UAE and Philips have partnered to allow access to Ultra-Low Contrast Percutaneous Coronary Intervention (ULC-PCI) to more patients in the Middle East, Turkey, and Africa. The new ULC-PCI Interventional Cardiology course at Al Qassimi Hospital is part of a global education program by Philips to share knowledge regarding the technology that can offer low-contrast, minimally invasive treatment for coronary artery disease, thereby spreading awareness among patients. Therefore, a surge in new product approvals, launches, and awareness in the field of cardiac microcatheters is expected to fuel the Europe and Middle East & Africa cardiac microcatheters market growth during the forecast period.

Indication Insights

Based on indication, the Europe and Middle East & Africa cardiac microcatheter market is bifurcated into general peripheral vascular and coronary. The coronary segment accounted for a larger market share in 2022 and is expected to register a higher CAGR in the Europe and Middle East & Africa cardiac microcatheter market. According to a study, “Cardiovascular Diseases in Central and Eastern Europe,” published in 2020, cardiovascular diseases are the leading cause of death in Europe, accounting for 45% of all deaths. There is a high prevalence of cardiovascular risk factors in Central and Western Europe, owing to smoking habits and heavy drinking consumption rates among men. More than 4 million Europeans die yearly from cardiovascular diseases, mainly coronary artery disease and stroke.

Cardiac Microcatheter Market, by Indication – 2022 and 2028

End User Insight

Based on end user, the Europe and Middle East & Africa cardiac microcatheter market is segmented into hospitals, specialty clinics, ambulatory surgical centers. The hospitals segment accounted for the largest market share in 2022. However, the specialty clinics segment is expected to register the highest CAGR of the Europe and Middle East & Africa cardiac microcatheter market during the forecast period.

Company Profiles

• Boston Scientific Corp
• Teleflex Inc
• Medtronic Plc
• OrbusNeich Medical Group Holdings Ltd
• Asahi Intecc USA Inc
• Merit Medical Systems Inc
• Nipro Corp
• Terumo Corp
• Tokai Medical Products Inc.
• Integer Holdings Corp

Europe and Middle East & Africa Cardiac Microcatheters Market Report Scope

Europe and Middle East & Africa Cardiac Microcatheters Market Players Density: Understanding Its Impact on Business Dynamics

The Europe and Middle East & Africa Cardiac Microcatheters Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.